ClinVar Miner

Submissions for variant NM_000304.4(PMP22):c.35A>G (p.His12Arg)

dbSNP: rs1909248652
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV001036010 SCV001199353 likely pathogenic Charcot-Marie-Tooth disease, type I 2019-01-25 criteria provided, single submitter clinical testing This variant disrupts the p.His12 amino acid residue in PMP22. Other variant(s) that disrupt this residue have been observed in individuals with PMP22-related conditions (PMID: 7728152, 26102530, 10078969, 15474367), suggesting that it is a clinically significant residue. As a result, variants that disrupt this residue are likely to be causative of disease. This variant has been reported to affect PMP22 protein function (PMID: 10915775). This variant has not been reported in the literature in individuals with PMP22-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change replaces histidine with arginine at codon 12 of the PMP22 protein (p.His12Arg). The histidine residue is highly conserved and there is a small physicochemical difference between histidine and arginine. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic.
Gene Discovery Core-Manton Center, Boston Children's Hospital RCV001548774 SCV001768739 pathogenic Charcot-Marie-Tooth disease, type IA 2020-02-14 no assertion criteria provided research This variant is interpreted as Pathogenic for Charcot-Marie-Tooth disease, type I; Autosomal Dominant. PS2-De novo (both maternity and paternity confirmed) in a patient with the disease and no family history. PM1- Located in a mutational hot spot and/or critical and well-established functional domain (e.g., active site of an enzyme) without benign variation. PM2- Absent from controls (gnomad). PM5- Novel missense change at an amino acid residue where a different missense change determined to be pathogenic has been seen before (PMID: 7728152). PP2- Missense variant in a gene that has a low rate of benign missense variation and in which missense variants are a common mechanism of disease. PP3- Multiple lines of computational evidence support a deleterious effect on the gene or gene product (conservation, evolutionary, splicing impact, etc.). PP5: Reputable source recently reports variant as pathogenic, but the evidence is not available to the laboratory to perform an independent evaluation (PMIDs: 7728152, 10078969, 10915775, 15474367 and 26102530).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.